Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update presents pharmacokinetics, safety, and efficacy data for the single-tablet Regimen of elvitegravir/cobicistat/emtricitabine/tenofovir dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infections

Drugs mentioned

• Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen

Snippet

Sponsor: Gilead Sciences | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-04-10